One of the three first volunteers receiving first shots of 50mcg dose of COVID-19 vaccine (Photo: VNA)
Hanoi (VNA) – Three first volunteers receivedthe first shot of a dose of 50mcg of Nanocovax COVID-19 vaccine on December 26morning.
Developed by the Nanogen PharmaceuticalBiotechnology JSC and the Vietnam Military Medical University, Nanocovax isVietnam's first COVID-19 candidate vaccine to reach the human trial stage.
A total of 60 volunteers, aged 18-50, were selectedfor the first phase of the clinical trials. They are divided into three groupsfor receiving three doses of 25 mcg, 50 mcg and 75 mcg, respectively. Thevaccination consists of two injections 28 days apart.
After the injection, the volunteers have been put underhealth monitoring at the Hanoi-based Military Medical University for 72 hours.The remaining 17 in the group will get injections of the 50mcg dose if thevaccine’s safety is confirmed.
The first group testing the 25 mcg dose received thefirst injections on December 17. According to Major General Hoang Van Luong,Deputy Director of the university, after the shots, all the 20 volunteers inthe group are in stable condition with no abnormal signs detected.
The first phase is scheduled to end after a monthand a half, during which the university will continue to select suitablevolunteers for the second, which is scheduled to begin in March 2021.
The participants will be under medical monitoringfor six months from the day they were given the first injection.
The Nanogen Pharmaceutical Biotechnology JSC hasspent 20 billion VND (865,946 USD) buying a health insurance package for thevolunteers.
Apart from Nanocovax, Vietnam has several otherCOVID-19 candidate vaccines being developed by Vabiotech, Polyvac, and theInstitute of Vaccines and Medical Biologicals./.
Six imported cases of COVID-19 were reported in the past 24 hours to 6pm on December 25, raising the national count to 1,439, according to the National Steering Committee for COVID-19 Prevention and Control.
Vietnam has not yet detected the new strain of coronavirus that has spread in the UK among legal immigrants, a health official affirmed on December 25.
More than 340 Vietnamese citizens in Russia were flown back to Vietnam on a flight of Vietnam Airlines at the arrangement of Vietnamese and Russian agencies on December 24-25.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.